SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-334698
Filing Date
2013-08-14
Accepted
2013-08-14 17:39:15
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d562054d10q.htm 10-Q 575640
2 EX-31.1 d562054dex311.htm EX-31.1 6981
3 EX-31.2 d562054dex312.htm EX-31.2 7013
4 EX-32.1 d562054dex321.htm EX-32.1 3799
5 EX-32.2 d562054dex322.htm EX-32.2 3832
  Complete submission text file 0001193125-13-334698.txt   4926855

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT idra-20130630.xml EX-101.INS 379355
7 XBRL TAXONOMY EXTENSION SCHEMA idra-20130630.xsd EX-101.SCH 49288
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE idra-20130630_cal.xml EX-101.CAL 39456
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE idra-20130630_def.xml EX-101.DEF 139518
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE idra-20130630_lab.xml EX-101.LAB 299584
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idra-20130630_pre.xml EX-101.PRE 201962
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 131038331
SIC: 2836 Biological Products, (No Diagnostic Substances)